Completed PHASE4 INTERVENTIONAL 1-arm NCT03158142

The Influence of Atropine on Choroidal Thickness

Sponsor: State University of New York College of Optometry

Conditions Myopia

Interventions Atropine Sulfate 1% Oph Soln

Updated 6 times since 2017 Last updated: Oct 10, 2018 Started: Mar 15, 2017 Primary completion: Nov 20, 2017 Completion: Nov 20, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Myopia and is currently completed. State University of New York College of Optometry leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Nov 2018 — Jan 2021 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Jun 2018 — Nov 2018 [monthly]

Recruiting PHASE4

▶ Show 1 earlier version

Jun 2017 — Jun 2018 [monthly]

Recruiting PHASE4

First recorded

Mar 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

State University of New York College of Optometry
The University of New South Wales

Data source: State University of New York College of Optometry

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States